Flurbiprofen.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Profiles of Drug Substances, Excipients and Related Methodology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/B978-0-12-397220-0.00004-0PMID 22469318
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Determination of flurbiprofen enantiomers in plasma using a single‐isomer amino cyclodextrin derivative in nonaqueous capillary electrophoresis

  2008cited by this paper
• Cloud point extraction-HPLC method for determination and pharmacokinetic study of flurbiprofen in rat plasma after oral and transdermal administration.

  2008cited by this paper
• Identification of flurbiprofen and its photoproducts in methanol by gas chromatography-mass spectrometry.

  2007cited by this paper
• Determination of ibuprofen and flurbiprofen in pharmaceuticals by capillary zone electrophoresis.

  2006cited by this paper
• Molecular Properties of Flurbiprofen and its Solid Dispersions with Eudragit RL100 Studied by High- and Low-Resolution Solid-State Nuclear Magnetic Resonance

  2006cited by this paper
• Disease‐modifying treatments for Alzheimer's disease: A perspective based on experience with R‐Flurbiprofen

  2006cited by this paper
• Molecular Properties of Ibuprofen and Its Solid Dispersions with Eudragit RL100 Studied by Solid-State Nuclear Magnetic Resonance

  2005cited by this paper
• Induction of apoptosis by R-flurbiprofen in human colon carcinoma cells: involvement of p53.

  2005cited by this paper
• Activity of flurbiprofen and chemically related anti-inflammatory drugs in models of Alzheimer's disease.

  2005cited by this paper
• New insights into the mode of action of anti-inflammatory drugs

  2005cited by this paper
• Nonsteroidal anti-inflammatory drugs (NSAIDs): a comparative QSAR study.

  2005cited by this paper
• Experimental optimization of enzymic kinetic resolution of racemic flurbiprofen

  2005cited by this paper
• A combined first principles computational and solid-state NMR study of a molecular crystal: flurbiprofen.

  2005cited by this paper
• Bioinversion of R-flurbiprofen to S-flurbiprofen at various dose levels in rat, mouse, and monkey.

  2004cited by this paper
• Resolution of 13C-19F interactions in the 13C NMR of spinning solids and liquid crystals.

  2004cited by this paper
• HPLC microdetermination of flurbiprofen enantiomers in plasma with a glycopeptide-type chiral stationary phase column.

  2004cited by this paper
• Enantioseparation of flurbiprofen and ketoprofen in patches and in urine excretions by achiral gas chromatography

  2004cited by this paper
• In vitro release and stereoselective disposition of flurbiprofen loaded to poly(D,L-lactide- co-glycolide) nanoparticles in rats.

  2004cited by this paper
• NSAIDs and enantiomers of flurbiprofen target gamma-secretase and lower Abeta 42 in vivo.

  2003cited by this paper
• Cyclooxygenase (COX) inhibitors: a comparative QSAR study.

  2003cited by this paper
• Stereospecific high-performance liquid chromatographic analysis of flurbiprofen: application to pharmacokinetic studies.

  2003cited by this paper
• Preparation of solid dispersions of nonsteroidal anti-inflammatory drugs with acrylic polymers and studies on mechanisms of drug-polymer interactions

  2002cited by this paper
• Efficient and selective microbial esterification with dry mycelium of Rhizopus oryzae.

  2001cited by this paper
• Elimination profiles of flurbiprofen and its metabolites in equine urine for doping analysis.

  2001cited by this paper
• Chiral resolution of flurbiprofen and ketoprofen enantiomers by HPLC on a glycopeptide-type column chiral stationary phase.

  2001cited by this paper
• Dehydrogenases and transaminases in asymmetric synthesis.

  2001cited by this paper
• Influence of alcohol concentration on lipase-catalyzed enantioselective esterification of racemic naproxen in isooctane: under controlled water activity*

  2000cited by this paper
• E-7869 (R-flurbiprofen) inhibits progression of prostate cancer in the TRAMP mouse.

  2000cited by this paper
• An improved broadband decoupling sequence for liquid crystals and solids.

  2000cited by this paper
• Sensitive and specific high-performance liquid chromatographic assay for 4'-hydroxyflurbiprofen and flurbiprofen in human urine and plasma.

  2000cited by this paper
• Mycelium-bound carboxylesterase from Aspergillus oryzae: an efficient catalyst for acetylation in organic solvent.

  2000cited by this paper
• Determination of flurbiprofen in serum by capillary isotachophoresis.

  1999cited by this paper
• Physicochemical characterization and preliminary in vivo efficacy of bioadhesive, semisolid formulations containing flurbiprofen for the treatment of gingivitis.

  1999cited by this paper
• Cyclooxygenase-1 and cyclooxygenase-2 selectivity of widely used nonsteroidal anti-inflammatory drugs.

  1998cited by this paper
• Radioprotective effects of flurbiprofen and its nitroderivative.

  1998cited by this paper
• Comparative study of the analgesic efficacy of flurbiprofen and diclofenac in patients following excimer laser photorefractive keratectomy.

  1998cited by this paper
• Enantiomers of flurbiprofen can distinguish key pathophysiological steps of NSAID enteropathy in the rat

  1998cited by this paper
• An alternative high-performance liquid chromatographic method for the determination of diclofenac and flurbiprofen in plasma.

  1998cited by this paper
• Effect of the NSAID flurbiprofen on remodelling after periodontal surgery.

  1997cited by this paper
• Methods of analysis of chiral non-steroidal anti-inflammatory drugs.

  1997cited by this paper
• High-performance thin-layer chromatographic determination of flurbiprofen in plasma.

  1997cited by this paper
• The efficacy of ANSAID (flurbiprofen) as an analgesic in foot surgery.

  1997cited by this paper
• Radioprotective properties of flurbiprofen.

  1996cited by this paper
• Efficacy and tolerance of diclofenac sodium 0.1%, flurbiprofen 0.03%, and indomethacin 1.0% in controlling postoperative inflammation

  1996cited by this paper
• Effect of the enantiomers of flurbiprofen, ibuprofen, and ketoprofen on intestinal permeability.

  1996cited by this paper
• Prostaglandin Endoperoxide H Synthases (Cyclooxygenases)-1 and −2*

  1996cited by this paper
• Antiproliferative Effects of the Enantiomers of Flurbiprofen

  1996cited by this paper
• Evaluation of topical 0.03% flurbiprofen drops in the treatment of herpetic stromal keratitis.

  1996cited by this paper
• Clinical Pharmacokinetics of Flurbiprofen and its Enantiomers

  1995cited by this paper
• Use of high-performance liquid chromatography-diode array detection in forensic toxicology.

  1995cited by this paper
• Effects of flurbiprofen enantiomers on pain-related chemo-somatosensory evoked potentials in human subjects.

  1995cited by this paper
• Role of cytochrome P450 2C9 and an allelic variant in the 4'-hydroxylation of (R)- and (S)-flurbiprofen.

  1995cited by this paper
• Stereoselective disposition of flurbiprofen in healthy subjects following administration of the single enantiomers.

  1994cited by this paper
• The X-ray crystal structure of the membrane protein prostaglandin H2 synthase-1

  1994cited by this paper
• Drug Chirality: On the Mechanism of R‐Aryl Propionic Acid Class NSAIDs. Epimerization in Humans and the Clinical Implications for the Use of Racemates

  1994cited by this paper
• Antinociceptive actions of R(-)-flurbiprofen--a non-cyclooxygenase inhibiting 2-arylpropionic acid--in rats.

  1994cited by this paper
• Rationale for the development of stereochemically pure enantiomers: are the R enantiomers of chiral nonsteroidal anti-inflammatory drugs inactive?

  1994cited by this paper
• Coupling of HPLC with 19F- and 1H-NMR spectroscopy to investigate the human urinary excretion of flurbiprofen metabolites.

  1993cited by this paper
• The effects of liver and renal disease on stereoselective serum binding of flurbiprofen.

  1993cited by this paper
• Protein Binding and Stereoselectivity of Nonsteroidal Anti-Inflammatory Drugs

  1993cited by this paper
• R-flurbiprofen: isomeric ballast or active entity of the racemic compound?

  1993cited by this paper
• Evaluation of flurbiprofen for prevention of reinfarction and reocclusion after successful thrombolysis or angioplasty in acute myocardial infarction. The Flurbiprofen French Trial.

  1993cited by this paper
• Stereoselective disposition of flurbiprofen in normal volunteers.

  1992cited by this paper
• Stereoselective disposition of flurbiprofen in uraemic patients.

  1992cited by this paper
• Variability of inversion of (R)-flurbiprofen in different species.

  1992cited by this paper
• Stereoselective high-performance liquid chromatographic determination of flurbiprofen in human plasma.

  1992cited by this paper
• Effects of pure enantiomers of flurbiprofen in comparison to racemic flurbiprofen on eicosanoid release from various rat organs ex vivo.

  1991cited by this paper
• Pharmacokinetic Comparison of Flurbiprofen in End‐Stage Renal Disease Subjects and Subjects with Normal Renal Function

  1991cited by this paper
• Plasma protein binding of flurbiprofen: enantioselectivity and influence of pathophysiological status.

  1989cited by this paper
• High-performance liquid chromatographic analysis of the enantiomers of flurbiprofen and its metabolites in plasma and urine.

  1989cited by this paper
• Stereoselective pharmacokinetics of flurbiprofen in humans and rats.

  1988cited by this paper
• Simultaneous determination of flurbiprofen and its major metabolite in physiological fluids using liquid chromatography with fluorescence detection.

  1987cited by this paper
• Pharmacokinetics of flurbiprofen.

  1986cited by this paper
• Predictive relationships in the water solubility of salts of a nonsteroidal anti-inflammatory drug.

  1985cited by this paper
• Determination of flurbiprofen in human serum by reverse-phase high-performance liquid chromatography with fluorescence detection.

  1984cited by this paper
• Determination of flurbiprofen and ibuprofen in dog serum with automated sample preparation.

  1981cited by this paper
• The disposition and metabolism of flurbiprofen in several species including man.

  1978cited by this paper
• Some biological properties of flurbiprofen, an anti-inflammatory, analgesic and antipyretic agent.

  1975cited by this paper
• Antagonism of slow reacting substance in anaphylaxis (SRS-A) and other spasmogens on the guinea pig tracheal chain by hydratropic acids and their effects on anaphylaxis.

  1975cited by this paper

• Enhanced transdermal delivery of flurbiprofen via eutectic mixtures and novel terpene ester derivatives of L-amino acids.

  2025cites this paper
• Mechanistic Investigation into Crystallization of Hydrated Co-Amorphous Systems of Flurbiprofen and Lidocaine

  2025influential citation
• In-depth summary of adverse events associated with Flurbiprofen: A real-world pharmacovigilance study from 2004 to 2024 using the FAERS database

  2025cites this paper
• The Quest for Secondary Pharmaceuticals: Drug Repurposing/Chiral-Switches Combination Strategy.

  2023cites this paper
• Flurbiprofen inhibits heme induced NLRP3 inflammasome in Berkeley sickle cell disease mice

  2023cites this paper
• Bis-conjugation of Bioactive Molecules to Cisplatin-like Complexes through (2,2'-Bipyridine)-4,4'-Dicarboxylic Acid with Optimal Cytotoxicity Profile Provided by the Combination Ethacrynic Acid/Flurbiprofen.

  2020cites this paper
• Biotransformation of the Fluorinated Nonsteroidal Anti‐Inflammatory Pharmaceutical Flurbiprofen in Activated Sludge Results in Accumulation of a Recalcitrant Fluorinated Aromatic Metabolite

  2019cites this paper
• Production and purification of an alkaline lipase from Bacillus sp. for enantioselective resolution of (±)-Ketoprofen butyl ester

  2018cites this paper
• Enantioselective resolution of 2-arylpropionic acid derivatives employing immobilization of lipase from Bacillus subtilis strain Kakrayal_1 (BSK-L).

  2018cites this paper
• Pharmacokinetics and efficacy of intraocular flurbiprofen

  2017cites this paper
• Sustained release of intravitreal flurbiprofen from a novel drug‐in‐liposome‐in‐hydrogel formulation☆

  2017cites this paper
• A Highly Enantioselective Alkene Methoxycarbonylation Enables a Concise Synthesis of (S)‐Flurbiprofen

  2017cites this paper
• Determining Partition Coefficient (Log P), Distribution Coefficient (Log D) and Ionization Constant (pKa) in Early Drug Discovery.

  2016cites this paper
• Flurbiprofen: A Nonselective Cyclooxygenase (COX) Inhibitor for Treatment of Noninfectious, Non-necrotizing Anterior Scleritis

  2016cites this paper
• Carbon nanotubes buckypapers for potential transdermal drug delivery.

  2015cites this paper
• Effects of flurbiprofen axetil on postoperative serum IL-2 and IL-6 levels in patients with colorectal cancer.

  2015cites this paper
• IUPAC-NIST Solubility Data Series. 102. Solubility of Nonsteroidal Anti-inflammatory Drugs (NSAIDs) in Neat Organic Solvents and Organic Solvent Mixtures

  2014cites this paper